| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 1,085 | 1,152 | 1,150 | 1,024 | 1,106 | 1,176 | 1,257 | 1,630 | 1,164 | 1,229 | 1,258 | 1,175 | 1,108 | 1,081 | 1,156 | 1,164 | 1,528 | 1,170 | 1,277 | 1,178 | 1,133 | 614 | 1,029 | 1,205 | 1,278 | 1,733 | 1,475 | 1,487 | 1,391 | 1,519 | 1,682 | 1,586 | 1,669 | 1,667 | 1,788 | 1,699 | 1,803 | 1,873 | 2,006 | 1,975 | 2,032 | 2,198 | 2,381 | 2,277 |
| Expenses | 1,022 | 986 | 1,087 | 1,066 | 1,091 | 1,059 | 1,097 | 1,023 | 1,045 | 1,071 | 1,138 | 1,069 | 1,907 | 1,034 | 1,172 | 1,193 | 1,069 | 996 | 1,028 | 1,012 | 987 | 709 | 875 | 987 | 1,055 | 1,135 | 1,178 | 1,180 | 1,157 | 1,237 | 1,304 | 1,283 | 1,372 | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,613 | 1,553 | 1,625 | 1,676 | 1,775 | 1,805 |
| EBITDA | 62 | 166 | 62 | -42 | 15 | 118 | 160 | 607 | 118 | 158 | 120 | 106 | -799 | 47 | -16 | -29 | 459 | 174 | 250 | 166 | 146 | -96 | 155 | 218 | 223 | 598 | 297 | 307 | 234 | 282 | 378 | 302 | 297 | 282 | 349 | 303 | 398 | 356 | 393 | 422 | 406 | 522 | 606 | 472 |
| Operating Profit % | 3 % | 4 % | -2 % | -5 % | -2 % | 6 % | 8 % | 10 % | 7 % | 7 % | 5 % | 5 % | -76 % | 1 % | -3 % | -8 % | 10 % | 13 % | 15 % | 13 % | 11 % | -17 % | 12 % | 16 % | 16 % | 20 % | 19 % | 20 % | 16 % | 17 % | 19 % | 18 % | 16 % | 16 % | 19 % | 17 % | 21 % | 18 % | 19 % | 19 % | 19 % | 23 % | 24 % | 20 % |
| Depreciation | 61 | 53 | 0 | 0 | 72 | 48 | 52 | 60 | 63 | 59 | 61 | 59 | 60 | 57 | 56 | 60 | 60 | 71 | 71 | 70 | 80 | 72 | 74 | 73 | 72 | 73 | 75 | 76 | 77 | 74 | 77 | 83 | 82 | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 | 102 | 106 | 120 |
| Interest | 37 | 34 | 30 | 32 | 38 | 42 | 46 | 75 | 67 | 64 | 66 | 63 | 64 | 76 | 85 | 111 | 65 | 51 | 49 | 48 | 57 | 41 | 42 | 42 | 41 | 38 | 40 | 38 | 30 | 31 | 33 | 33 | 32 | 32 | 32 | 33 | 35 | 35 | 36 | 45 | 68 | 70 | 75 | 86 |
| Profit Before Tax | -22 | 88 | 44 | -58 | -96 | 28 | 62 | 472 | -11 | 35 | -7 | -17 | -924 | -87 | -157 | -201 | 334 | 52 | 130 | 48 | 9 | -208 | 38 | 103 | 110 | 486 | 182 | 193 | 126 | 176 | 268 | 186 | 183 | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 | 351 | 425 | 266 |
| Tax | -10 | -9 | -17 | -29 | -8 | 3 | 24 | 19 | 26 | 12 | 17 | 3 | -9 | -34 | -15 | -20 | 183 | -26 | 6 | 118 | 50 | -20 | 23 | 49 | 48 | 56 | 51 | 51 | 39 | 42 | 50 | 44 | 45 | 47 | 49 | 49 | 68 | 56 | 68 | 25 | 49 | 84 | 97 | 68 |
| Net Profit | -12 | 97 | 61 | -29 | -88 | 25 | 38 | 453 | -38 | 23 | -24 | -19 | -914 | -53 | -142 | -180 | 151 | 78 | 124 | -69 | -41 | -188 | 16 | 54 | 62 | 431 | 131 | 142 | 87 | 134 | 218 | 142 | 138 | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 | 267 | 329 | 197 |
| EPS in ₹ | -0.38 | 2.01 | 1.19 | -0.65 | -1.91 | 0.35 | 0.68 | 9.49 | -0.79 | 0.10 | -0.88 | -0.71 | -17.97 | -1.36 | -3.21 | -3.06 | 1.80 | 0.90 | 1.47 | -1.01 | -0.59 | -2.37 | -0.05 | 0.40 | 0.57 | 3.49 | 1.42 | 1.55 | 0.90 | 1.62 | 2.71 | 1.72 | 1.76 | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 |
Fortis Healthcare
Fortis Healthcare
892.55
-28.40
(-3.08%)
Market Cap
67,383.79 Cr
PE Ratio
70.89
Volume
13,09,652.00
Day High - Low
927.85 - 890.15
52W High-Low
1,104.30 - 595.60
Key Fundamentals
Market Cap
67,383.79 Cr
EPS
10.26
PE Ratio
70.89
PB Ratio
7.37
Book Value
124.90
EBITDA
1,654.90
Dividend Yield
0.11 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
8.83
Debt to Equity
0.22
Analyst Rating and Forecast
- By Refinitiv from15 analysts
Actual
Company News
View All News
Fortis Healthcare's composite scheme of merger by absorption involving five wholly-owned subsidiaries becomes effective March 1, 2026, following NCLT order filing with Registrar of Companies.
Northern TK Venture Pte Ltd amends its claim against Daiichi Sankyo in Tokyo District Court following completion of open offers on November 10, 2025, seeking damages worth INR109,299,359,054.
Fortis Healthcare Limited has issued a postal ballot notice seeking shareholder approval for its Employee Stock Option Scheme 2026, covering up to 1,50,99,163 stock options for employees across the company and its subsidiaries.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,724.50 | #1 1,11,066.46 | 59.92 | #1 21,994.30 | 14.76 | #1 1,505 | 36.08 | 62.84 | |
1,042.00 | 1,01,362.57 | 72.54 | 7,184.10 | #1 28.65 | 1,076 | 26.01 | 45.23 | |
892.55 | #3 67,383.79 | #6 70.89 | #2 7,849.70 | #7 13.25 | #3 809 | #7 -22.38 | 45.70 | |
1,755.30 | 35,871.45 | 46.38 | 5,575.00 | 12.29 | 790 | -34.33 | 42.18 | |
672.70 | 34,854.00 | 94.61 | 4,286.70 | 15.12 | 337 | -8.85 | 71.15 | |
1,110.10 | 29,838.42 | 58.12 | 3,771.40 | 12.59 | 481 | -33.52 | 43.64 | |
720.60 | 28,834.01 | 89.42 | 3,067.00 | 21.98 | 415 | -43.89 | 60.07 | |
443.25 | 14,027.53 | 88.46 | 1,757.00 | 27.64 | 110 | #1 54.61 | 43.06 | |
1,199.40 | 12,181.01 | 47.18 | 1,566.90 | 17.46 | 244 | 7.26 | 48.64 | |
5,289.00 | 11,728.31 | #1 24.23 | 599.90 | 11.69 | 58 | 12.46 | 48.75 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
13.25 %
Net Income Growth
25.45 %
Cash Flow Change
29.44 %
ROE
17.11 %
ROCE
0.92 %
EBITDA Margin (Avg.)
11.89 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 | 13,692 |
| Fixed Assets | 4,218 | 3,776 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 | 10,424 |
| Current Assets | 1,636 | 1,434 | 1,775 | 1,282 | 1,667 | 941 | 1,037 | 1,133 | 1,406 | 1,421 | 1,471 |
| Capital Work in Progress | 228 | 201 | 268 | 226 | 450 | 204 | 165 | 194 | 228 | 542 | 407 |
| Investments | 616 | 1,449 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 | 169 |
| Other Assets | 2,554 | 1,807 | 2,152 | 1,672 | 2,755 | 2,167 | 2,005 | 2,172 | 2,569 | 2,643 | 2,692 |
| Total Equity & Liabilities | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 | 13,692 |
| Current Liabilities | 1,602 | 1,476 | 1,927 | 2,134 | 3,591 | 2,579 | 1,233 | 1,269 | 1,426 | 3,170 | 1,607 |
| Non Current Liabilities | 1,813 | 1,616 | 1,480 | 1,171 | 1,248 | 1,563 | 3,204 | 3,607 | 2,907 | 1,563 | 2,915 |
| Total Equity | 4,201 | 4,140 | 6,311 | 5,317 | 7,113 | 7,206 | 6,718 | 7,008 | 8,100 | 8,556 | 9,169 |
| Reserve & Surplus | 3,585 | 3,534 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 | 8,162 |
| Share Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 | 755 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -66 | -38 | 225 | -513 | 799 | -627 | 212 | -153 | -22 | 125 | -70 |
| Investing Activities | 213 | 122 | -1,001 | -333 | -3,279 | 64 | -131 | -501 | -373 | -889 | -780 |
| Operating Activities | 24 | 195 | 967 | 493 | -179 | 172 | 486 | 865 | 822 | 1,100 | 1,424 |
| Financing Activities | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -87 | -714 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 26.32 % | 0.00 % | 23.24 % | 23.31 % | 25.26 % | 26.77 % | 27.40 % | 27.17 % | 27.90 % | 27.84 % |
| DIIs | 13.44 % | 15.20 % | 15.66 % | 15.50 % | 16.72 % | 17.44 % | 19.94 % | 20.38 % | 20.70 % | 22.16 % | 26.55 % | 29.35 % | 31.15 % | 32.31 % | 30.73 % | 30.05 % | 29.46 % | 29.79 % | 29.14 % | 29.33 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.96 % | 15.16 % | 15.98 % | 14.89 % | 13.96 % | 13.58 % | 12.92 % | 12.39 % | 12.05 % | 11.80 % | 11.13 % | 11.04 % | 10.82 % | 10.47 % | 10.36 % | 10.21 % | 10.22 % | 10.17 % | 10.14 % | 10.14 % |
| Others | 41.43 % | 38.47 % | 37.20 % | 38.44 % | 38.15 % | 37.82 % | 35.98 % | 36.06 % | 36.08 % | 34.86 % | 4.83 % | 28.44 % | 3.63 % | 2.75 % | 2.48 % | 1.81 % | 1.75 % | 1.70 % | 1.65 % | 1.53 % |
| No of Share Holders | 0 | 1,09,889 | 1,44,634 | 1,66,743 | 1,54,572 | 1,56,881 | 1,60,762 | 1,58,455 | 1,37,894 | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 | 2,20,766 | 2,33,156 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.14 | 0.11 | 0.00 |
Announcements
Effective Date Of Scheme Of Arrangement- Merger By Absorption
4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 20, 2026
Feb 20, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) Regarding A Material Litigation Filed By Northern TK Venture Pte Ltd. (NTK) The Promoter Shareholder Of The Company Against Feb 19, 2026
Feb 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Feb 17, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements Regulations 2015- Notice Of Postal BallotFeb 16, 2026
Feb 16, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Feb 14, 2026Revision In Related Party Transaction PolicyFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 13, 2026
Feb 13, 2026Outcome Of The Board Meeting-13-02-2026Feb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of The Board Meeting-13-02-2026Feb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Feb 06, 2026Board Meeting Intimation for Board Meeting Intimation For Prior Intimation Of Board Meeting Under Regulation 29 And 50 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 06, 2026
Feb 06, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 23, 2026
Jan 23, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 23, 2026
Jan 23, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jan 22, 2026
Jan 22, 2026Announcement Regarding Scheme Of Merger By Absorption Between Wholly Owned SubsidiariesJan 16, 2026
Jan 16, 2026Announcement under Regulation 30 (LODR)-Scheme of ArrangementJan 16, 2026
Jan 16, 2026Update On Acquisition Of TMI Healthcare Private LimitedJan 09, 2026
Jan 09, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 08, 2026
Jan 08, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2026
Jan 07, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2026
Jan 07, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 07, 2026
Jan 07, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Credit RatingJan 06, 2026
Jan 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 05, 2026
Jan 05, 2026Disclosure Under Regulation 30 Of SEBI Listing Regulations For Receipt Of GST OrdersDec 30, 2025
Dec 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 24, 2025
Dec 24, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements Regulations 2015- Notice Of Postal BallotDec 23, 2025
Dec 23, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements Regulations 2015- Notice Of Postal BallotDec 23, 2025
Dec 23, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 23, 2025
Dec 23, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 23, 2025
Dec 23, 2025Certificate Of Payment Of Interest To Debenture HoldersDec 22, 2025
Dec 22, 2025Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD Dec 22, 2025
Dec 22, 2025Closure of Trading WindowDec 22, 2025
Dec 22, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 20, 2025
Dec 20, 2025Disclosure On Signing Of Definitive Agreements For Acquisition Of TMI Healthcare Private LimitedDec 20, 2025
Dec 20, 2025Disclosure Under Regulation 30 And 51 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Dec 19, 2025
Dec 19, 2025Disclosure Under Regulation 30 And 51 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Dec 19, 2025
Dec 19, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 19, 2025
Dec 19, 2025Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended On November 30 2025Dec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 17, 2025
Dec 17, 2025Newspaper Clippings - Special Window For Re-Lodgement Of Transfer Requests Of Physical SharesDec 17, 2025
Dec 17, 2025Disclosure Under Regulation 30 And 51 Of SEBI (Listing Obligations & Disclosure Requirements)
Regulations 2015 (SEBI Listing Regulations)Dec 04, 2025
Dec 04, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Dec 03, 2025
Dec 03, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 18, 2025
Nov 18, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 18, 2025
Nov 18, 2025Status Of Re-Lodgement Of Transfer Requests Of Physical Shares For The Months Ended On 30Th October 2025.Nov 18, 2025
Nov 18, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 53.82
ATR(14)
Less Volatile 24.79
STOCH(9,6)
Neutral 52.90
STOCH RSI(14)
Oversold 9.10
MACD(12,26)
Bullish 0.21
ADX(14)
Weak Trend 22.35
UO(9)
Bearish 56.24
ROC(12)
Uptrend And Accelerating 0.57
WillR(14)
Neutral -70.04
About Fortis Healthcare
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child...more
Listing Date
09 May, 2007(18 Years,
25 days)
Chairperson NameLeo Puri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
